Overview

Location:
Israel
Employees:
11-50
Business Model:
B2C
Category:
Biotechnology, Health Care, Medical Device
Company Overview:

V-Wave Ltd. founded in 2010 the company is a privately held company with offices in Israel and the US. The company is focused on developing percutaneous implantable devices for treating patients with chronic Heart Failure (HF).

As a leading cause of death and hospitalization, HF continues to affect millions of people worldwide. V-Wave’s vision is to help patients who remain with disabling symptoms or need hospitalization despite optimized medical treatment.

V-Wave has developed a proprietary unidirectional inter-atrial shunt intended to relieve symptoms, reduce hospitalization, increase exercise capacity and improve the overall quality of life.

The original concept and development started in Israel with a talented team of engineers and medical scientists. The company’s senior management has decades of experience successfully developing, clinically testing and bringing to market multiple implantable cardiovascular devices.

Founders:

Yaacov Nitzan
Co-Founder
Gad Keren
Co-Founder
Ascher Shmulewitz
Co-Founder

Leading Investors:

  • BRM Group

  • Pontifax

Financing Rounds:

Content & Privacy:

Confidentiality:
PrivatEquity, the online trading arena, provides a balance between the private shareholders (employees and former employees) need to protect its confidential information and the investor’s need for the transparency necessary to make an informed investment decision.
Content Sources:
All the information presented above was retrieved from public sources (media, company website, data from the registrar of private shareholder, etc.).
Responsibility:
PrivatEquity does not accept any responsibility or liability for the accuracy, content and reliability of this information.
Diversify your investments portfolio with investments that provide access to private securities and pre-IPO leading high-tech private growth companies.

The offering and selling of securities in this site is restricted only to 'Accredited Investors' as defined in the first supplement of the Israeli Securities Law, 5728-1968

Got A Question? Ask Us Now:

Full Name: *

Email: *

Telephone:

Your message:

Follow Us:
Design by: